vs
林德（LIN）与Sensus Healthcare, Inc.（SRTS）财务数据对比。点击上方公司名可切换其他公司
林德的季度营收约是Sensus Healthcare, Inc.的1777.9倍（$8.8B vs $4.9M），林德同比增速更快（8.2% vs -62.2%），林德自由现金流更多（$898.0K vs $-2.4M），过去两年林德的营收复合增速更高（3.1% vs -31.9%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
Sensus Healthcare, Inc.是一家医疗科技企业，主营无创浅表放射治疗设备的研发、生产与商业化，产品主要用于治疗非黑素瘤皮肤癌、瘢痕疙瘩及部分皮肤美容相关病症，服务全球各地的医疗机构与临床场所。
LIN vs SRTS — 直观对比
营收规模更大
LIN
是对方的1777.9倍
$4.9M
营收增速更快
LIN
高出70.4%
-62.2%
自由现金流更多
LIN
多$3.3M
$-2.4M
两年增速更快
LIN
近两年复合增速
-31.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.8B | $4.9M |
| 净利润 | — | $-3.2M |
| 毛利率 | 48.5% | 38.4% |
| 营业利润率 | 27.8% | -63.8% |
| 净利率 | — | -64.1% |
| 营收同比 | 8.2% | -62.2% |
| 净利润同比 | — | -304.9% |
| 每股收益（稀释后） | $3.98 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINSRTS
| Q1 26 | $8.8B | — | ||
| Q4 25 | $8.8B | $4.9M | ||
| Q3 25 | $8.6B | $6.9M | ||
| Q2 25 | $8.5B | $7.3M | ||
| Q1 25 | $8.1B | $8.3M | ||
| Q4 24 | $8.3B | $13.1M | ||
| Q3 24 | $8.4B | $8.8M | ||
| Q2 24 | $8.3B | $9.2M |
净利润LINSRTS
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-3.2M | ||
| Q3 25 | $1.9B | $-943.0K | ||
| Q2 25 | $1.8B | $-1.0M | ||
| Q1 25 | $1.7B | $-2.6M | ||
| Q4 24 | $1.7B | $1.5M | ||
| Q3 24 | $1.6B | $1.2M | ||
| Q2 24 | $1.7B | $1.6M |
毛利率LINSRTS
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% |
营业利润率LINSRTS
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -63.8% | ||
| Q3 25 | 27.5% | -37.3% | ||
| Q2 25 | 27.7% | -26.6% | ||
| Q1 25 | 26.9% | -31.7% | ||
| Q4 24 | 27.4% | 13.2% | ||
| Q3 24 | 25.0% | 16.9% | ||
| Q2 24 | 26.4% | 21.5% |
净利率LINSRTS
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -64.1% | ||
| Q3 25 | 22.4% | -13.7% | ||
| Q2 25 | 20.8% | -14.2% | ||
| Q1 25 | 20.6% | -30.8% | ||
| Q4 24 | 20.8% | 11.8% | ||
| Q3 24 | 18.5% | 13.7% | ||
| Q2 24 | 20.1% | 17.4% |
每股收益（稀释后）LINSRTS
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-0.19 | ||
| Q3 25 | $4.09 | $-0.06 | ||
| Q2 25 | $3.73 | $-0.06 | ||
| Q1 25 | $3.51 | $-0.16 | ||
| Q4 24 | $3.61 | $0.10 | ||
| Q3 24 | $3.22 | $0.07 | ||
| Q2 24 | $3.44 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0B | $22.1M |
| 总债务越低越好 | $24.7B | — |
| 股东权益账面价值 | $40.1B | $48.1M |
| 总资产 | $86.3B | $53.0M |
| 负债/权益比越低杠杆越低 | 0.62× | — |
8季度趋势，按日历期对齐
现金及短期投资LINSRTS
| Q1 26 | $4.0B | — | ||
| Q4 25 | $5.1B | $22.1M | ||
| Q3 25 | $4.5B | $24.5M | ||
| Q2 25 | $4.8B | $22.2M | ||
| Q1 25 | $5.3B | $19.1M | ||
| Q4 24 | $4.8B | $22.1M | ||
| Q3 24 | $5.2B | $22.6M | ||
| Q2 24 | $4.6B | $19.0M |
总债务LINSRTS
| Q1 26 | $24.7B | — | ||
| Q4 25 | $20.7B | — | ||
| Q3 25 | $18.6B | — | ||
| Q2 25 | $19.7B | — | ||
| Q1 25 | $17.6B | — | ||
| Q4 24 | $15.3B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $16.9B | — |
股东权益LINSRTS
| Q1 26 | $40.1B | — | ||
| Q4 25 | $38.2B | $48.1M | ||
| Q3 25 | $38.6B | $51.2M | ||
| Q2 25 | $38.5B | $52.1M | ||
| Q1 25 | $38.0B | $53.0M | ||
| Q4 24 | $38.1B | $55.8M | ||
| Q3 24 | $39.2B | $54.1M | ||
| Q2 24 | $38.2B | $52.9M |
总资产LINSRTS
| Q1 26 | $86.3B | — | ||
| Q4 25 | $86.8B | $53.0M | ||
| Q3 25 | $86.0B | $58.3M | ||
| Q2 25 | $86.1B | $58.9M | ||
| Q1 25 | $82.7B | $60.2M | ||
| Q4 24 | $80.1B | $62.2M | ||
| Q3 24 | $82.5B | $59.9M | ||
| Q2 24 | $80.2B | $58.2M |
负债/权益比LINSRTS
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.2M |
| 自由现金流经营现金流 - 资本支出 | $898.0K | $-2.4M |
| 自由现金流率自由现金流/营收 | 0.0% | -47.9% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | $332.0K |
8季度趋势，按日历期对齐
经营现金流LINSRTS
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-2.2M | ||
| Q3 25 | $2.9B | $2.3M | ||
| Q2 25 | $2.2B | $3.1M | ||
| Q1 25 | $2.2B | $-2.7M | ||
| Q4 24 | $2.8B | $-827.0K | ||
| Q3 24 | $2.7B | $4.0M | ||
| Q2 24 | $1.9B | $4.2M |
自由现金流LINSRTS
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | $-2.4M | ||
| Q3 25 | $1.7B | $2.3M | ||
| Q2 25 | $954.0M | $3.1M | ||
| Q1 25 | $891.0M | $-2.7M | ||
| Q4 24 | $1.6B | $-1.1M | ||
| Q3 24 | $1.7B | $3.6M | ||
| Q2 24 | $796.0M | $4.2M |
自由现金流率LINSRTS
| Q1 26 | 0.0% | — | ||
| Q4 25 | 17.9% | -47.9% | ||
| Q3 25 | 19.4% | 33.3% | ||
| Q2 25 | 11.2% | 42.2% | ||
| Q1 25 | 11.0% | -32.2% | ||
| Q4 24 | 18.8% | -8.6% | ||
| Q3 24 | 19.9% | 40.9% | ||
| Q2 24 | 9.6% | 45.8% |
资本支出强度LINSRTS
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 3.2% | ||
| Q3 25 | 14.8% | 0.1% | ||
| Q2 25 | 14.8% | 0.4% | ||
| Q1 25 | 15.7% | 0.1% | ||
| Q4 24 | 15.1% | 2.3% | ||
| Q3 24 | 12.8% | 3.8% | ||
| Q2 24 | 13.7% | 0.0% |
现金转化率LINSRTS
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.29× | — | ||
| Q4 24 | 1.63× | -0.53× | ||
| Q3 24 | 1.76× | 3.25× | ||
| Q2 24 | 1.16× | 2.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIN
暂无分部数据
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
